Form 4: Moderna CFO James Mock Reports Stock Transactions

Chief Financial Officer of Moderna, James Mock, reports the acquisition and disposal of company stock and restricted stock units on January 3, 2025.

Summary

• James Mock, the Chief Financial Officer of Moderna, filed a Form 4 detailing changes in beneficial ownership of the company's securities.
• On January 3, 2025, Mock exercised restricted stock units, converting 1,453 units into common stock.
• Also on January 3, 2025, Mock disposed of 780 shares of common stock to cover tax withholding obligations at a price of $42 per share.
• Following these transactions, Mock directly owns 11,739 shares of Moderna common stock and 10,169 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing. It simply reports transactions and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of key personnel at Moderna.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect insider trading activity, which is a normal part of corporate governance.

Key Dates